Double-blind Rumalon trial in bilateral knee osteoarthritis
E. Adler, E. Wolf, I. Taustein · 1987 · Scandinavian Journal of Rheumatology 16(1), 6–11
Indexed 2026-11-12.
Reported findings and study design
Reported findings
Double-blind comparison of cartilage and bone marrow extract against placebo. The abstract gives the overall enrollment.
Dose, route and schedule
Double-blind comparison of cartilage and bone marrow extract against placebo. The abstract gives the overall enrollment.
Protocol source ↗ · Original indexed abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Author-rated favorable response | 64% with Rumalon versus 29% with placebo (p<0.05). |
The abstract omits arm sizes, injection schedule, the exact response definition and adverse-event counts.
Source for these results ↗ · Reviewed 2026-11-12
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The abstract omits arm sizes, injection schedule, the exact response definition and adverse-event counts.
Source access
Original indexed abstract
Source reviewed 2026-11-12.
Citation and original source
Original source: E. Adler, E. Wolf, I. Taustein. Double-blind Rumalon trial in bilateral knee osteoarthritis Scandinavian Journal of Rheumatology 16(1), 6–11 1987.
Molekul research summary: https://molekul.io/research/rumalon-adler-1987. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry